The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population
Abstract
Mental health problems are endemic across the globe, and suicide, a strong corollary of poor mental health, is a leading cause of death. Classic psychedelic use may occasion lasting improvements in mental health, but the effects of classic psychedelic use on suicidality are unknown. We evaluated the relationships of classic psychedelic use with psychological distress and suicidality among over 190,000 USA adult respondents pooled from the last five available years of the National Survey on Drug Use and Health (2008–2012) while controlling for a range of covariates. Lifetime classic psychedelic use was associated with a significantly reduced odds of past month psychological distress (weighted odds ratio (OR)=0.81 (0.72–0.91)), past year suicidal thinking (weighted OR=0.86 (0.78–0.94)), past year suicidal planning (weighted OR=0.71 (0.54–0.94)), and past year suicide attempt (weighted OR=0.64 (0.46–0.89)), whereas lifetime illicit use of other drugs was largely associated with an increased likelihood of these outcomes. These findings indicate that classic psychedelics may hold promise in the prevention of suicide, supporting the view that classic psychedelics’ most highly restricted legal status should be reconsidered to facilitate scientific study, and suggesting that more extensive clinical research with classic psychedelics is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
KESSLER, R. C., ANDREWS, G., COLPE, L. J., HIRIPI, E., MROCZEK, D. K., NORMAND, S.-L. T., WALTERS, E. E., & ZASLAVSKY, A. M. (2002) · Psychological Medicine · doi:10.1017/s0033291702006074 · Cited by 10,327
The world health report 2001 - Mental health: new understanding, new hope
Sayers, J. G. (2001) · Europe PMC (PubMed Central) · doi:10.1590/s0042-96862001001100014 · Cited by 3,123
Good practice in the conduct and reporting of survey research
KELLEY, K. (2003) · International Journal for Quality in Health Care · doi:10.1093/intqhc/mzg031 · Cited by 2,157
Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0457-5 · Cited by 1,684
Drug harms in the UK: a multicriteria decision analysis
Nutt, D. J., King, L. A., & Phillips, L. D. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61462-6 · Cited by 1,681
Hawton, K., & van Heeringen, K. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60372-x · Cited by 1,671
Default Mode Network Activity and Connectivity in Psychopathology
Whitfield-Gabrieli, S., & Ford, J. M. (2012) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032511-143049 · Cited by 1,465
Kessler, R. C., Green, J. G., Gruber, M. J., Sampson, N. A., Bromet, E., Cuitan, M., Furukawa, T. A., Gureje, O., Hinkov, H., Hu, C., et al. (2010) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.310 · Cited by 1,434
Development of a rational scale to assess the harm of drugs of potential misuse
Nutt, D., King, L. A., Saulsbury, W., & Blakemore, C. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60464-4 · Cited by 1,302
Neurobiology of suicidal behaviour
Mann, J. J. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1220 · Cited by 1,260
Carhart-Harris, R. L., Leech, R., Hellyer, P. J., Shanahan, M., Feilding, A., Tagliazucchi, E., Chialvo, D. R., & Nutt, D. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00020 · Cited by 1,252
Nichols, D. E. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.11.002 · Cited by 1,211
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Grob, C. S., Danforth, A. L., Chopra, G. S., Hagerty, M., McKay, C. R., Halberstadt, A. L., & Greer, G. R. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.116 · Cited by 1,206 · cited 1×
“In a pilot trial among individuals with advancedstage cancer a single dose of psilocybin was associated with long-term reductions in anxiety and depression (Grob et al., 2011), and in a pilot trial among individuals with life-threatening diseases two administrations of LSD produced lasting reductions in anxiety (Gasse…”
BackgroundHuman hallucinogen research: guidelines for safety
Johnson, M., Richards, W., & Griffiths, R. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108093587 · Cited by 1,203
Self-citationNeural correlates of the psychedelic state as determined by fMRI studies with psilocybin
Carhart-Harris, R. L., Erritzoe, D., Williams, T., Stone, J. M., Reed, L. J., Colasanti, A., Tyacke, R. J., Leech, R., Malizia, A. L., Murphy, K., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119598109 · Cited by 1,172
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
Griffiths, R. R., Johnson, M. W., Richards, W. A., Richards, B. D., McCann, U., & Jesse, R. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2358-5 · Cited by 932
Self-citationPilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction
Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P., & Griffiths, R. R. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114548296 · Cited by 914 · cited 1×
“Furthermore, a single-arm trial of smoking cessation involving up to three administrations of psilocybin yielded abstinence rates of 80% at long-term follow-up, more than doubling abstinence rates typical of approved contemporary tobacco dependence interventions (Johnson et al., 2014).”
BackgroundSelf-citationGriffiths, R., Richards, W., Johnson, M., McCann, U., & Jesse, R. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108094300 · Cited by 905
Self-citationMacLean, K. A., Johnson, M. W., & Griffiths, R. R. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111420188 · Cited by 895
Self-citationKashdan, T. B., Rose, P., & Fincham, F. D. (2004) · Journal of Personality Assessment · doi:10.1207/s15327752jpa8203_05 · Cited by 888 · cited 1×
“Although these interests may be lasting effects of classic psychedelic drug use, they may also represent predrug characteristics among classic psychedelic users that might protect against suicide as well (e.g. openness, curiosity, and spiritual tendencies; Carhart-Harris et al., 2014; Kashdan et al., 2004; Rasic et al…”
BackgroundDwivedi, Y., Rizavi, H. S., Conley, R. R., Roberts, R. C., Tamminga, C. A., & Pandey, G. N. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.8.804 · Cited by 875
Gasser, P., Holstein, D., Michel, Y., Doblin, R., Yazar-Klosinski, B., Passie, T., & Brenneisen, R. (2014) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0000000000000113 · Cited by 750
The neurobiology of psychedelic drugs: implications for the treatment of mood disorders
Vollenweider, F. X., & Kometer, M. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2884 · Cited by 723
Wilcox, H. C., Conner, K. R., & Caine, E. D. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.08.003 · Cited by 720
Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials
Krebs, T. S., & Johansen, P.-Ø. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112439253 · Cited by 583
Värnik, P. (2012) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph9030760 · Cited by 481
Broadband Cortical Desynchronization Underlies the Human Psychedelic State
Muthukumaraswamy, S. D., Carhart-Harris, R. L., Moran, R. J., Brookes, M. J., Williams, T. M., Errtizoe, D., Sessa, B., Papadopoulos, A., Bolstridge, M., Singh, K. D., et al. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2063-13.2013 · Cited by 475
Gasser, P., Kirchner, K., & Passie, T. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114555249 · Cited by 456
The role of religion and spirituality in mental health
Weber, S. R., & Pargament, K. I. (2014) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000080 · Cited by 409
Associations of Substance Use, Abuse, and Dependence with Subsequent Suicidal Behavior
Borges, G., Walters, E. E., & Kessler, R. C. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010278 · Cited by 403
Enhanced repertoire of brain dynamical states during the psychedelic experience
Tagliazucchi, E., Carhart‐Harris, R., Leech, R., Nutt, D., & Chialvo, D. R. (2014) · Human Brain Mapping · doi:10.1002/hbm.22562 · Cited by 397
Black, C., & Miller, B. J. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.10.014 · Cited by 366
Psychedelics and mental health: a population study
Krebs, T. S., & Johansen, P.-Ø. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063972 · Cited by 347
Effects of Schedule I drug laws on neuroscience research and treatment innovation
Nutt, D. J., King, L. A., & Nichols, D. E. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3530 · Cited by 337
Kraehenmann, R., Preller, K. H., Scheidegger, M., Pokorny, T., Bosch, O. G., Seifritz, E., & Vollenweider, F. X. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.04.010 · Cited by 323
Roseman, L., Leech, R., Feilding, A., Nutt, D. J., & Carhart-Harris, R. L. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00204 · Cited by 272
Dysfunctional Attitudes and 5-HT2 Receptors During Depression and Self-Harm
Meyer, J. H., McMain, S., Kennedy, S. H., Korman, L., Brown, G. M., DaSilva, J. N., Wilson, A. A., Blak, T., Eynan-Harvey, R., Goulding, V. S., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.1.90 · Cited by 264
Carhart-Harris, R. L., Leech, R., Williams, T. M., Erritzoe, D., Abbasi, N., Bargiotas, T., Hobden, P., Sharp, D. J., Evans, J., Feilding, A., et al. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.103309 · Cited by 237
Spirituality, religion and suicidal behavior in a nationally representative sample
Rasic, D. T., Belik, S.-L., Elias, B., Katz, L. Y., Enns, M., & Sareen, J. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.08.007 · Cited by 234
Bhagwagar, Z., Hinz, R., Taylor, M., Fancy, S., Cowen, P., & Grasby, P. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.9.1580 · Cited by 214
Rasic, D., Robinson, J. A., Bolton, J., Bienvenu, O. J., & Sareen, J. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.11.014 · Cited by 211
Szabo, A., Kovacs, A., Frecska, E., & Rajnavolgyi, E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106533 · Cited by 191
Shelton, R. C., Sanders‐Bush, E., Manier, D. H., & Lewis, D. A. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.11.036 · Cited by 149
Voice of the Psychonauts: Coping, Life Purpose, and Spirituality in Psychedelic Drug Users
Móró, L., Simon, K., Bárd, I., & Rácz, J. (2011) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2011.605661 · Cited by 145
Bogenschutz, M. P., & Pommy, J. M. (2012) · Drug Testing and Analysis · doi:10.1002/dta.1376 · Cited by 130
Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles
Baumeister, D., Barnes, G. L., Giaroli, G., & Tracy, D. K. (2014) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125314527985 · Cited by 127
Brain-derived neurotrophic factor and suicide pathogenesis
Dwivedi, Y. (2010) · Annals of Medicine · doi:10.3109/07853890903485730 · Cited by 116
Values and Beliefs of Psychedelic Drug Users: A Cross-Cultural Study
Lerner, M., & Lyvers, M. (2006) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2006.10399838 · Cited by 98
Hendricks, P. S., Clark, C. B., Johnson, M. W., Fontaine, K. R., & Cropsey, K. L. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881113513851 · Cited by 98
Self-citationNeurobiology of Suicidal Behavior. An Integration of Biological and Clinical Findings
Carballo, J. J., Akamnonu, C. P., & Oquendo, M. A. (2008) · Archives of Suicide Research · doi:10.1080/13811110701857004 · Cited by 91
Lyvers, M., & Meester, M. (2012) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2012.736842 · Cited by 91
National Survey on Drug Use and Health, 2008
United States Department Of Health And Human Services. Substance Abuse And Mental Health Services Administration. Office Of Applied Studies (2009) · ICPSR Data Holdings · doi:10.3886/icpsr26701 · Cited by 89
National Survey on Drug Use and Health, 2011
United States Department Of Health And Human Services. Substance Abuse And Mental Health Services Administration. Center For Behavioral Health Statistics And Quality (2012) · ICPSR Data Holdings · doi:10.3886/icpsr34481 · Cited by 87
Personality, Suicidal Ideation, and Reasons for Living among Older Adults
Segal, D. L., Marty, M. A., Meyer, W. J., & Coolidge, F. L. (2011) · The Journals of Gerontology Series B · doi:10.1093/geronb/gbr080 · Cited by 84
National Survey on Drug Use and Health, 2010
United States Department Of Health And Human Services. Substance Abuse And Mental Health Services Administration. Center For Behavioral Health Statistics And Quality (2011) · ICPSR Data Holdings · doi:10.3886/icpsr32722 · Cited by 72
Suicide Attempts within 12 Months of Treatment for Substance Use Disorders
Britton, P. C., & Conner, K. R. (2010) · Suicide and Life-Threatening Behavior · doi:10.1521/suli.2010.40.1.14 · Cited by 56
A new look at the construct validity of the K6 using Rasch analysis
Khan, A., Chien, C., & Burton, N. W. (2014) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1431 · Cited by 20
Cited by
Nichols, D. E. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011478 · Cited by 1,762
Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M. J., Erritzoe, D., Kaelen, M., Bloomfield, M., Rickard, J. A., Forbes, B., Feilding, A., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30065-7 · Cited by 1,540
REBUS and the anarchic brain: Toward a unified model of the brain action of psychedelics
Carhart-Harris, R. L., & Friston, K. J. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.017160 · Cited by 1,180
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
Carhart-Harris, R. L., Bolstridge, M., Day, C. M. J., Rucker, J., Watts, R., Erritzoe, D. E., Kaelen, M., Giribaldi, B., Bloomfield, M., Pilling, S., et al. (2018) · Psychopharmacology · doi:10.1007/s00213-017-4771-x · Cited by 970
Serotonin and brain function: a tale of two receptors
Carhart-Harris, R., & Nutt, D. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117725915 · Cited by 739
Metadata
- Authors
- Hendricks, P. S., Thorne, C. B., Clark, C. B., Coombs, D. W., & Johnson, M. W.
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2015-01-13
- Volume
- 29
- Issue
- 3
- Pages
- 280-288
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W1997161439
- Cited by
- 381
- References
- 57
- FWCI
- 38.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.